CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 4 Open-market sale EVP, R&D AND CSO sold 12,342 shares at $7.06 ($87,135)
- 4 Open-market sale EVP, R&D AND CSO sold 50,000 shares at $6.76 ($338,000)
- 4 Open-market buy Director bought 13,008,546 shares at $3.84 ($49,952,817)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 103,907 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 1,245 shares at $7.21 ($8,982)
- 4 Option exercise EVP, R&D AND CSO acquired 17,847 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP, R&D AND CSO acquired 20,728 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 6 · 119 filings